JPMorgan Chase & Co. (JPM.VI)
| Previous close | 191.50 |
| Open | 194.32 |
| Bid | 0.00 x 0 |
| Ask | 189.36 x 0 |
| Day's range | 189.18 - 194.38 |
| 52-week range | 128.80 - 194.38 |
| Volume | |
| Avg. volume | 33 |
| Market cap | 545.567B |
| Beta (5Y monthly) | 1.11 |
| PE ratio (TTM) | 12.26 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 4.23 (2.20%) |
| Ex-dividend date | 05 Jul 2024 |
| 1y target est | N/A |
- Business Wire
JPMorgan Chase Announces 2024 Dodd-Frank Act Stress Test Results
NEW YORK, June 28, 2024--JPMorgan Chase & Co. (NYSE: JPM) ("JPMorgan Chase" or the "Firm") announced today that it has released the results of its company-run 2024 Dodd-Frank Act Stress Test for JPMorgan Chase & Co. and JPMorgan Chase Bank, National Association. Information can be found on the Firm's website at www.jpmorganchase.com under Investor Relations, Events & Presentations, 2024 Dodd-Frank Act Stress Test Results.
- Business Wire
JPMorgan Chase Regulatory Capital Update
NEW YORK, June 28, 2024--JPMorgan Chase & Co. (NYSE: JPM) ("JPMorgan Chase" or the "Firm") has announced updated information relating to its third quarter dividend, common share repurchase program and regulatory capital requirements. Information can be found on the Firm’s Investor Relations website at jpmorganchase.com/ir/news.
- Business Wire
JPMorgan Chase Comments on the Federal Reserve’s 2024 Stress Test Results
NEW YORK, June 27, 2024--JPMorgan Chase & Co. (NYSE: JPM) ("JPMorgan Chase" or the "Firm") has reviewed the Federal Reserve’s 2024 stress test results and specifically the Federal Reserve’s projections for Other Comprehensive Income ("OCI"). Based on the Firm’s own assessment, the benefit in OCI appears to be too large. Should the Firm’s analysis be correct, the resulting stress losses would be modestly higher than those disclosed by the Federal Reserve.
